Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder [2]

Kidney International

Volumn 57, Issue 4, 2000, Pages 1776-1777

  Gallieni, M ^a   Cozzolino, M ^a   Brancaccio, D ^a  

^a SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CALCIUM CARBONATE; PHOSPHATE; PHOSPHATE BINDING AGENT; SEVELAMER;

DRUG EFFICACY; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; LETTER; METABOLIC ACIDOSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0034127441     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00025.x     Document Type: Letter

References (4)

1. G.A. Block T.E. Hulbert-Shearon N.W. Levin F.K. Port Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study Am J Kidney Dis 31 1998 607 617
2. E.A. Slatopolsky S.K. Burke M.A. Dillon RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group Kidney Int 55 1999 299 307
3. G.M. Chertow S.K. Burke J.M. Lazarus K.H. Stenzel D. Wombolt D. Goldberg J.V. Bonventre E. Slatopolsky Poly[allylamine hydrochloride] (Renagel): A non calcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure Am J Kidney Dis 29 1997 66 71
4. D.A. Bushinsky The contribution of acidosis to renal osteodystrophy Kidney Int 47 1995 1816 1832